Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia

Abstract

Get full access to this article

View all access options for this article.

References

Saida

Kikuchi

Itoyama

. A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis. Mult Scler J. [Epub ahead of print 21 February 2012, DOI: 10.1177/1352458511435984].

Budde

Schmouder

Brunkhorst

. First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients. J Am Soc Nephrol 2002; 13: 1073-1083.

Scott

. Fingolimod. A review of its use in the management of relapsing–remitting multiple sclerosis. CNS Drugs 2011; 25: 673-698.

Kovarik

Slade

Voss

. Ethnic sensitivity study of fingolimod in white and Asian subjects. Int J Clin Pharmacol Ther 2007; 45: 98-109.